CD19 chimeric antigen receptor T-cell therapy improved lung function and skin thickness in patients with severe refractory ...

Large language models, when used alongside human clinical judgement, “substantially” improved diagnostic accuracy among a ...

Enpatoran, a first-in-class oral small molecule toll-like receptor 7/8 inhibitor, is superior to placebo in improving mucocutaneous symptoms of cutaneous and systemic lupus, according to data ...

Self-care and taking time to enjoy “sacred moments” can help reduce burnout and improve work-life balance for physicians, ...

Results presented at the American Association of Hip and Knee Surgeons Annual Meeting showed synthetic THC may not reduce ...

A cementless, anatomic ceramic hip resurfacing device may be safe and effective, with a low all-cause revision rate at 8-year ...

The FDA has approved once-daily oral Lynkuet for the treatment of moderate to severe hot flashes caused by menopause, ...

Preliminary results presented here showed use of a custom-tailored AI platform may be a feasible option to address ...

Patients staying in hospital rooms with multiple beds are at an increased risk — up to ninefold higher — for Staphylococcus aureus transmission compared with patients in single-bed rooms, according to ...

The FDA approved revumenib for patients aged 1 year and older with relapsed or refractory acute myeloid leukemia with a ...

Academic medicine can be a rewarding path filled with opportunities for personal and professional growth, from teaching ...

The FDA declined to approve SYD-101, a low-dose atropine formulation that would have been the first pharmaceutical treatment ...